MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announced today that the annual meeting of stockholders will be held at the offices of Lippert/Heilshorn & Associates, Inc., 800 Third Avenue, 17th Floor, New York, New York, on September 7, 2011 at 10:00 a.m. Eastern time. For security purposes, photo identification will be required for admission to the building.
